logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Asuka Okada

Saiseikai Suita Hospital
H指数:11
被引数:402

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Regimen selection for combined immunotherapy in non-small cell lung cancer with PD-L1 < 1%: a multicenter, retrospective study from Japan (SPIRAL-LT1)

PD-L1<1%的非小细胞肺癌联合免疫治疗方案选择：一项来自日本的多中心回顾性研究（SPIRAL-LT1）

Scientific Reports
IF3.9
2026-10-160
OAAI
Daiki Murata; Koichi Azuma; Kenta Murotani; Kazuhiro Ito; Takashi Nomizo; Kazuhiko Yamada; Tatsuya Imabayashi; Kentaro Iwanaga; Kenji Chibana; Takayo Ota; Yuuya Nishii; Akira Nakao; Asuka Okada; Kosuke Hamai; Keiko Tanimura; Kohei Yoshimine; Yosuke Tamura; Ryuichiro Takaki; Yasuhiro Goto; Makoto Hibino; Tomohiro Oba; Toshiyuki Sumi; Hiroyasu Kaneda; Naoya Nishioka; Tadaaki Yamada; Koichi Takayama
Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease

基线中性粒细胞与淋巴细胞比率可预测间质性肺病患者开始使用nintedanib后的生存时间

BMC Pulmonary Medicine
IF2.8
2026-05-190
OAAI
Shiho Goda; Tadaaki Yamada; Yasuhiro Goto; Sayaka Uda; Akira Nakao; Shinsuke Shiotsu; Yuji Kukida; Keiko Tanimura; Akifumi Miyamoto; Yuki Imasato; Asuka Okada; Isao Hasegawa; Koji Date; Yohei Matsui; Shoki Morito; Noeru Inokuchi; Shuji Osugi; Hayato Kawachi; Naoya Nishioka; Masahiro Iwasaku; Shinsaku Tokuda; Tomohiro Handa; Koichi Takayama
Identification of Hidden Cachexia Subgroup in PD-L1-High NSCLC: Comparative Analysis of the AWGC vs. Fearon Criteria

识别PD-L1高表达非小细胞肺癌中隐藏恶病质亚组：AWGC与Fearon标准的比较分析

journal of cachexia, sarcopenia and muscle
IF0
2026-04-120
OAAI
Naoya Nishioka; Hayato Kawachi; Tadaaki Yamada; Motohiro Tamiya; Yoshiki Negi; Yasuhiro Goto; Akira Nakao; Shinsuke Shiotsu; Keiko Tanimura; Takayuki Takeda; Asuka Okada; Taishi Harada; Koji Date; Yusuke Chihara; Isao Hasegawa; Nobuyo Tamiya; Takeo Ogawa; Masahiro Iwasaku; Shinsaku Tokuda; Takashi Kijima; Koichi Takayama
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancer

肠道微生物组驱动的肿瘤免疫微环境调控优化了晚期非小细胞肺癌的双检查点阻断

ESMO Open
IF8.3
2026-02-160
OAAI
Y. Katayama; A. Fukuda; R. Inoue; H. Kawachi; R. Sawada; T. Harada; A. Yoshimura; A. Okada; S. Shiotsu; Y. Chihara; Y. Takemura; T. Yamada; N. Nishioka; M. Iwasaku; S. Tokuda; T. Takagi; S. Kumagai; S. Koyama; K. Takayama; T. Yamada
Prognostic factors in patients with interstitial lung disease treated with nintedanib: a multicenter retrospective study in Japan

特发性肺间质疾病患者接受尼达尼布治疗后的预后因素：一项在日本进行的多中心回顾性研究

Scientific Reports
IF3.9
2025-12-270
OAAI
Shiho Goda; Tadaaki Yamada; Yasuhiro Goto; Sayaka Uda; Akira Nakao; Shinsuke Shiotsu; Yuji Kukida; Keiko Tanimura; Akifumi Miyamoto; Yuki Imasato; Asuka Okada; Isao Hasegawa; Koji Date; Yohei Matsui; Shoki Morito; Noeru Inoguchi; Shuji Osugi; Hayato Kawachi; Naoya Nishioka; Masahiro Iwasaku; Shinsaku Tokuda; Tomohiro Handa; Koichi Takayama
Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy

基于炎症选择最优免疫疗法：用于PD-L1 ≥50%基因突变阴性IV期非小细胞肺癌：帕博利珠单抗单药治疗与联合化疗免疫疗法

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2025-11-300
PRE
Kunimatsu, Yusuke; Nishioka, Naoya; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Ishida, Masaki; Kijima, Takashi; Takayama, Koichi
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression
ANTICANCER RESEARCH
IF1.7
2025-11-011
PRE
Sasada, Aosa; Kawachi, Hayato; Yamada, Tadaaki; Hata, Tae; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Okada, Asuka; Chihara, Yusuke; Kijima, Takashi; Takayama, Koichi
Attitudes toward social robots among parents of children with neurodevelopmental disorders: A questionnaire survey on a remote island in Japan

神经发育障碍儿童家长对社会机器人的态度：日本某偏远岛屿的问卷调查

PSYCHIATRY AND CLINICAL NEUROSCIENCES REPORTS
IF0.9
2025-10-150
OAAI
Maeda, Kengo; Kawashiri, Shin-Ya; Arima, Kazuhiko; Miyata, Jun; Niri, Tetsuro; Honda, Yukiko; Nonaka, Fumiaki; Koyanagi, Kenshi; Koyamatsu, Jun; Okada, Asuka; Ideguchi, Mai; Ichifuji, Yu; Adachi, Kohei; Maeda, Takahiro; Kumazaki, Hirokazu; Nagata, Yasuhiro
Immune checkpoint inhibitor-induced interstitial lung disease with and without CTLA-4 regimen in non-small cell lung cancer patients and PD-L1 < 1 %: A multicenter, retrospective study

免疫检查点抑制剂诱导的间质性肺病（合并与不合并CTLA-4方案）在PD-L1 < 1 %的非小细胞肺癌患者中的研究：一项多中心、回顾性研究

Lung Cancer
IF4.4
2025-09-260
PRE
Daiki Murata; Koichi Azuma; Kenta Murotani; Kazuhiro Ito; Takashi Nomizo; Kazuhiko Yamada; Tatsuya Imabayashi; Kentaro Iwanaga; Kenji Chibana; Takayo Ota; Yuuya Nishii; Akira Nakao; Asuka Okada; Kosuke Hamai; Keiko Tanimura; Kohei Yoshimine; Yosuke Tamura; Ryuichiro Takaki; Yasuhiro Goto; Makoto Hibino; Tomohiro Oba; Toshiyuki Sumi; Hiroyasu Kaneda; Naoya Nishioka; Tadaaki Yamada; Koichi Takayama
Pemetrexed plus platinum as second-line treatment for patients with pleural mesothelioma treated with nivolumab plus ipilimumab

培美曲塞联合铂类药物作为接受纳武利尤单抗联合伊匹木单抗治疗的患者中，恶性胸膜间皮瘤的二线治疗方案。

Lung Cancer
IF4.4
2025-08-120
PRE
Sawana Ono; Hirokazu Taniguchi; Koji Kuroda; Teppei Hashimoto; Asuka Okada; Yasuhiro Goto; Hidenori Kitai; Yoichi Nakamura; Shinsuke Ogusu; Tetsunari Hase; Takayo Ota; Noriyuki Ebi; Makoto Furugen; Taishi Harada; Yoshiaki Kinoshita; Takaki Mizoguchi; Katsumi Nakatomi; Yoshifumi Soejima; Takahiro Yamada; Shinnosuke Takemoto; Hiroshi Mukae
Osimertinib as First-Line Treatment for Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in a Real-World Setting: Updated Overall Survival Data (OSI-FACT-OS)

奥希替尼作为EGFR突变阳性晚期非小细胞肺癌患者一线治疗的真实世界研究：总体生存数据更新（OSI-FACT-OS）

Clinical Lung Cancer
IF3.3
2025-06-100
PRE
Yoshihiko Sakata; Go Saito; Shinya Sakata; Teppei Yamaguchi; Motohiro Tamiya; Hidekazu Suzuki; Ryota Shibaki; Asuka Okada; Toshihide Yokoyama; Hirotaka Matsumoto; Taiichiro Otsuki; Yuki Sato; Junji Uchida; Yoko Tsukita; Megumi Inaba; Hideki Ikeda; Daisuke Arai; Hirotaka Maruyama; Satoshi Hara; Shinsuke Tsumura; Jun Morinaga; Takuro Sakagami
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy
ONCOIMMUNOLOGY
IF6.3
2024-12-160
OAAI
Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Kijima, Takashi; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Shimose, Takayuki; Takayama, Koichi
Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005)

局部晚期非小细胞肺癌放化疗和巩固Durvalumab治疗后进展后后续化疗的真实世界结果: 来自CRIMSON研究的探索性分析 (HOPE-005)

CLINICAL LUNG CANCER
IF3.3
2024-11-012
PRE
Kawachi, Hayato; Tamiya, Motohiro; Oya, Yuko; Saito, Go; Taniguchi, Yoshihiko; Matsumoto, Hirotaka; Sato, Yuki; Otsuki, Taiichiro; Suzuki, Hidekazu; Fukuda, Yasushi; Tanaka, Satoshi; Tsukita, Yoko; Uchida, Junji; Sakata, Yoshihiko; Nakatani, Yuki; Shibaki, Ryota; Arai, Daisuke; Okada, Asuka; Hara, Satoshi; Takayama, Koichi; Nishino, Kazumi
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1%to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study

TTF-1表达对PD-L1表达水平为1%至49%的非小细胞肺癌患者预后预测的影响：化疗与化疗免疫治疗的多中心回顾性研究

CANCER RESEARCH AND TREATMENT
IF3.8
2024-10-250
OA
Nishioka, Naoya; Hata, Tae; Yamada, Tadaaki; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Hibino, Makoto; Okada, Asuka; Chihara, Yusuke; Kawachi, Hayato; Kijima, Takashi; Takayama, Koichi
Depth of response and treatment outcomes of immune checkpoint inhibitor-based therapy in patients with advanced non-small cell lung cancer and high PD-L1 expression: An exploratory analysis of retrospective multicenter cohort
INVESTIGATIONAL NEW DRUGS
IF2.7
2024-08-210
PRE
Tachibana, Yusuke; Morimoto, Kenji; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study
TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2024-08-010
OAAI
Kataoka, Nobutaka; Katayama, Yuki; Yamada, Tadaaki; Morimoto, Kenji; Takeda, Takayuki; Okada, Asuka; Shiotsu, Shinsuke; Chihara, Yusuke; Yamada, Takahiro; Hiranuma, Osamu; Ota, Takahiro; Harada, Taishi; Hasegawa, Isao; Nishioka, Naoya; Iwasaku, Masahiro; Tokuda, Shinsaku; Takayama, Koichi
Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study
FRONTIERS IN IMMUNOLOGY
IF5.9
2024-07-150
OAAI
Nishioka, Naoya; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Masui, Taiki; Sai, Natsuki; Ishida, Masaki; Katayama, Yuki; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi

研究方向

暂未获取到该数据
T
Tadaaki Yamada
H 指数:41论文数:563被引数:6,283
H
Hayato Kawachi
H 指数:16论文数:152被引数:1,115
K
Koichi Takayama
H 指数:75论文数:954被引数:1.9万
Y
Yusuke Chihara
H 指数:23论文数:157被引数:3,149
S
Shinsuke Shiotsu
H 指数:17论文数:121被引数:1,388
I
Isao Hasegawa
H 指数:33论文数:311被引数:4,769
T
Takayuki Takeda
H 指数:22论文数:196被引数:2,735
Y
Yasuhiro Gotô
H 指数:31论文数:334被引数:3,791
M
Motohiro Tamiya
H 指数:32论文数:372被引数:3,565
K
Keiko Tanimura
H 指数:13论文数:107被引数:1,057